BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Alba Therapeutics Corporation 

2400 Boston Street
Suite 302
Baltimore  Maryland  21224  U.S.A.
Phone: 410-319-0780 Fax: 410-319-0834


SEARCH JOBS


Industry
Biotechnology






 Company News
Alba Therapeutics Corporation Announces Positive Results Of Phase 2b Trial In Celiac Disease 2/11/2014 7:18:30 AM    More...
Alba Therapeutics Corporation Taps Wendy Perrow to Chief Executive Officer Post 11/6/2013 6:47:09 AM    More...
Alba Therapeutics Corporation Recruiting for a Phase 2b Clinical Trial and Gains Exclusive Rights to the First and Only Patient Reported Outcome Questionnaire for Patients with Celiac Disease 5/1/2012 12:31:24 PM    More...
Cephalon, Inc. (CEPH) Signs Option Agreement to Acquire Assets from Alba Therapeutics Corporation 2/10/2011 8:58:08 AM    More...
Biotech Cash Crunch Leads to Layoffs at Alba Therapeutics Corporation, Novavax, Inc. (NVAX) 1/26/2009 7:52:12 AM    More...
Alba Therapeutics Corporation Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease - Milestone Marks the First Time a European Patient with Active Celiac Disease has Enrolled in a Clinical Trial for an Investigational Medication from Alba Therapeutics 11/11/2008 10:21:04 PM    More...
2008 Mid-Atlantic Bio Exhibitor Profiles 10/21/2008 11:36:47 AM    More...
Alba Therapeutics Corporation Presents New Data for Larazotide Acetate at the 2008 American College of Gastroenterology Annual Scientific Meeting 10/7/2008 10:43:37 AM    More...
Alba Therapeutics Corporation Announces Promotions 10/3/2008 11:26:14 AM    More...
Alba Therapeutics Corporation Announces the Presentation of Results of a Phase IIa Clinical Trial 5/21/2008 10:46:49 AM    More...
12345

//-->